Marks Jason M. - 19 Aug 2022 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Aug 2022, 20:02:58 UTC
Prior SEC filing
03 May 2022
Next SEC filing
19 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason M. Marks

Key filing fact

Marks Jason M. filed Form 4 for AMARIN CORP PLC\UK (AMRN) on 23 Aug 2022.

Key facts

  • This page summarizes Marks Jason M.'s Form 4 filing for AMARIN CORP PLC\UK (AMRN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Aug 2022, 20:02.

Change

  • Previous filing in this sequence was filed on 03 May 2022.
  • Current net transaction value: -$18,267.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMRN transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+33,334
Change %
Price
Shares after
33,334
Date
19 Aug 2022
Ownership
Direct
Footnotes
F1, F2, F3
AMRN transaction

Ordinary Shares

Tax liability

Transaction value
$18,267
Shares
-11,417
Change %
-34%
Price
$1.60
Shares after
21,917
Date
19 Aug 2022
Ownership
Direct
Footnotes
F1, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMRN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-33,334
Change %
-33%
Price
$0.000000
Shares after
66,666
Date
19 Aug 2022
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
33,334
Exercise price
$0.000000
Footnotes
F1, F2, F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

On September 1, 2021, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. These RSUs vest in three equal installments on each of August 19, 2022, August 19, 2023 and August 19, 2024. The first vesting event occurred on August 19, 2022.

Footnote F3

Not applicable.

Footnote F4

Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Footnote F5

Please see the section titled "Remarks" below for additional information.

Footnote F6

Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

SEC remarks

In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 746,583 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .